Evidence map›Paper›PMID 20856859›Full record

ArticlePLoS neglected tropical diseases2010

Application and validation of PFGE for serovar identification of Leptospira clinical isolates.

Renee L Galloway, Paul N Levett

Open access · goldAbstract readComparative StudyEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 74 citations in OpenAlex.

  1. Shaping the future ofJournal of medical microbiology · 2025
    Review
  2. Article
  3. Article
  4. Isolation of VirulentMicroorganisms · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Genomic Comparison Among Global Isolates ofFrontiers in cellular and infection microbiology · 2018
    Article
  9. Characterization of Leptospira isolates from humans and the environment in Uruguay.Revista do Instituto de Medicina Tropical de Sao Paulo · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Identification of Leptospira serovars by RFLP of the RNA polymerase beta subunit gene (rpoB).Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2015
    Article
  14. Article
  15. Leptospirosis in humans.Current topics in microbiology and immunology · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Renee L GallowayBacterial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. zul0@CDC.GOV
Paul N Levett
Centers for Disease Control and Prevention · USSaskatchewan Disease Control Laboratory · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serovar identification of clinical isolates of Leptospira is generally not performed on a routine basis, yet the identity of an infecting serovar is valuable from both epidemiologic and public health standpoints. Only a small number of reference laboratories worldwide have the capability to perform the cross agglutinin absorption test (CAAT), the reference method for serovar identification. Pulsed-field gel electrophoresis (PFGE) is an alternative method to CAAT that facilitates rapid identification of leptospires to the serovar level. We employed PFGE to evaluate 175 isolates obtained from humans and animals submitted to the Centers for Disease Control and Prevention (CDC) between 1993 and 2007. PFGE patterns for each isolate were generated using the NotI restriction enzyme and compared to a reference database consisting of more than 200 reference strains. Of the 175 clinical isolates evaluated, 136 (78%) were identified to the serovar level by the database, and an additional 27 isolates (15%) have been identified as probable new serovars. The remaining isolates yet to be identified are either not represented in the database or require further study to determine whether or not they also represent new serovars. PFGE proved to be a useful tool for serovar identification of clinical isolates of known serovars from different geographic regions and a variety of different hosts and for recognizing potential new serovars.

Indexed as

AnimalsBacterial Typing TechniquesCluster AnalysisDeoxyribonucleases, Type II Site-SpecificDNA, BacterialDNA FingerprintingElectrophoresis, Gel, Pulsed-FieldGenotypeHumansLeptospiraLeptospirosisDeoxyribonucleases, Type II Site-SpecificDNA, BacterialGCGGCCGC-specific type II deoxyribonucleases

Identifiers

PMID20856859
PMCPMC2939049
OpenAlexW1992460734

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.